Educatieplatform voor farmacotherapie en FTO
Inloggen
FTO.nu
Kennisquiz
Nieuws
Field Safety Notice: Abbott - ARCHITECT Estradiol Reagent
vrijdag 8 april 2016 16:00
Abbott has confirmed that the drug Fulvestrant (Faslodex®) may interfere with the ARCHITECT Estradiol assay (LN 7K72) leading to falsely elevated Estradiol results.
www.igz.nl/...waarschuwingen/abbott---architect-estradiol-reagent.aspx
Vorige
Overzicht
Volgende